Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis, Lancet, vol.382, issue.9901, pp.1329-1369, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00925590
Epidemiology of peripheral artery disease, Circ Res, vol.116, issue.9, pp.1509-1535, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01233163
Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome, Diabetes Care, vol.24, issue.8, pp.1433-1440, 2001. ,
Impact of peripheral arterial disease in patients with diabetes--results from PROactive ,
, Atherosclerosis, vol.202, issue.1, pp.272-81, 2009.
Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCEON study, Cardiovasc Diabetol, vol.15, issue.1, p.129, 2016. ,
Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States, Circ Cardiovasc Qual Outcomes, vol.3, issue.6, pp.642-51, 2010. ,
Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis, Eur Heart J, vol.34, issue.34, pp.2706-2720, 2013. ,
Psychosocial outcome in cardiovascular rehabilitation of peripheral artery disease and coronary artery disease patients, Vasc Med, vol.18, issue.5, pp.257-62, 2013. ,
Burden of peripheral arterial disease in Europe and the United States: a patient survey, Health Qual Life Outcomes, vol.11, p.175, 2013. ,
microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes, Diabetes Care, vol.39, issue.10, pp.1796-803, 2016. ,
UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes, Diabetes Care, vol.25, issue.5, pp.894-903, 2002. ,
Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial, Diabetes Care, vol.37, issue.5, pp.1346-52, 2014. ,
Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative metaanalysis of individual participant data, Lancet Diabetes Endocrinol, vol.5, issue.9, pp.718-746, 2017. ,
Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease?, Atherosclerosis, vol.197, issue.1, pp.1-11, 2008. ,
Treadmill exercise-induced release of endothelin-1 in patients with peripheral arterial occlusive disease at Fontaine stage IIb, Int Angiol, vol.19, issue.1, pp.14-21, 2000. ,
Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort, Prognostic values of inflammatory and redox status biomarkers on the risk of major lower-extremity artery disease in subjects with type 2 diabetes, vol.17, pp.331-340, 1992. ,
Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study, Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, vol.285, pp.1119-1150, 2001. ,